认知障碍中的VCAM-1:机制,生物标志物潜力和治疗向
Xilong Guan1,2, Xiaoling Zhu1,2, Linan Zha1,2
1Department of Anesthesiology, Yingtan City People's Hosptial, Yingtan, Jiangxi, China.
血管细胞粘附分子1 (VCAM-1) 通过破坏血脑屏障并增加神经炎症,导致认知障碍. 了解VCAM-1可能会导致对痴呆症和阿尔茨海默病的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 认知障碍 (CI) 影响10%的65岁以上成年人,每年有15%的成年人发展为痴呆症.
- 阿尔茨海默病 (AD) 和血管痴呆 (VaD) 是主要的痴呆症形式,预计到2050年将影响1.52亿人.
- 血管细胞粘附分子1 (VCAM-1) 是一种免疫-炎症调解剂,涉及CI.
研究的目的:
- 审查VCAM-1在血脑屏障 (BBB) 失调和神经炎症在认知障碍中的作用.
- 探索VCAM-1作为潜在的生物标志物和CI的治疗点.
主要方法:
- 文献综述侧重于VCAM-1在CI病变发生过程中的参与.
- 分析VCAM-1在内皮细胞中的功能及其对BBB完整性的影响.
- 检查VCAM-1对神经炎症过程的贡献.
主要成果:
- VCAM-1在内皮细胞上表达,破坏了BBB的完整性.
- VCAM-1会加剧神经炎症,导致认知能力下降.
- VCAM-1具有作为CI生物标志物和治疗点的潜力.
结论:
- VCAM-1在认知障碍的发病过程中发挥着重要作用.
- 针对VCAM-1可能为早期CI管理提供战略.
- 需要进一步的研究来阐明VCAM-1信号和开发干预措施.
更多相关视频
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
